Companies
PFE
PFIZER INC
Pfizer is a large pharmaceutical company with a diversified portfolio including commercial-stage products across multiple therapeutic areas such as vaccines, primary care, specialty care, and oncology, utilizing modalities including small molecules, biologics, and biosimilars. The company's revenue is concentrated in blockbuster products including Eliquis, a small molecule anticoagulant, alongside numerous other marketed drugs, though the company faces significant revenue headwinds from patent expirations anticipated between 2026 and 2030. Pfizer competes against generic and biosimilar manufacturers, newer branded competitors, and international companies with expanding R&D capabilities, with pricing pressures intensifying across vaccines, branded products, and biosimilar portfolios.
$26.70+17.36%1Y
PFE · daily close · illustrative · 0 catalysts marked
Pipeline
Phase 3Neoplasms
Phase 3Breast Cancer
Phase 3Atopic Dermatitis
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Non-muscle-invasive Bladder Cancer
Phase 3Intestinal Neoplasms
Phase 3Gastrointestinal Neoplasms
Phase 3Digestive System Neoplasms
Phase 3Neoplasms by Site
Phase 3Digestive System Diseases
Phase 3Gastrointestinal Diseases
Phase 3Colonic Diseases
Phase 3Intestinal Diseases
Phase 3Rectal Diseases
Phase 3Colorectal Neoplasms
Phase 3Neoplasms
Phase 3Melanoma
Phase 3Multiple Myeloma
Phase 3Diffuse Large B-Cell Lymphoma
Phase 3Clostridioides Difficile Associated Disease
Phase 2Breast Cancer
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 3Neoplasms
Phase 3Urothelial Carcinoma
Phase 2Colorectal Neoplasms
Phase 2Exocrine Pancreatic Cancer
Phase 2Carcinoma, Squamous Cell of Head and Neck
Phase 2Non-Small Cell Lung Cancer
Phase 3Multiple Myeloma
Phase 3Colorectal Neoplasms
Phase 2Metastatic Colorectal Cancer
Phase 3Neoplasms
Phase 2Breast Cancer
Phase 2Head and Neck Cancer
Phase 2Small Cell Lung Cancer
Phase 2Transformed Small Cell Lung Cancer
Phase 2Lung Neoplasms
Phase 2Carcinoma, Small Cell Lung
Phase 2Small Cell Cancer Of The Lung
Phase 3Intestinal Neoplasms
Phase 3Gastrointestinal Neoplasms
Phase 3Digestive System Neoplasms
Phase 3Neoplasms by Site
Phase 3Digestive System Diseases
Phase 3Gastrointestinal Diseases
Phase 3Colonic Diseases
Phase 3Intestinal Diseases
Phase 3Rectal Diseases
Phase 3Colorectal Neoplasms
Phase 2/3Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma
Phase 2/3Metastatic Gastric Cancer
Phase 2/3Gastroesophageal Junction Cancer
Phase 2/3Esophageal Adenocarcinoma
Phase 3Advanced Non-Small Cell Lung Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Metastatic Non-small Cell Lung Cancer
Phase 3Lung Cancer
Phase 3Advanced Non-Small Cell Lung Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Metastatic Non-small Cell Lung Cancer
Phase 3Lung Cancer
Phase 3Urothelial Carcinoma
Phase 2Colorectal Neoplasms
Phase 2Exocrine Pancreatic Cancer
Phase 2Carcinoma, Squamous Cell of Head and Neck
Phase 2Non-Small Cell Lung Cancer
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Breast Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Multiple Myeloma
Phase 3Multiple Myeloma
Phase 3Urothelial Carcinoma
Phase 2Breast Cancer
Phase 2Ovarian Neoplasms
Phase 2Endometrial Neoplasms
Phase 2Head and Neck Neoplasms
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2HER2 Low Breast Neoplasms
Phase 2HER2 Positive Breast Neoplasms
Phase 2Stomach Neoplasms
Phase 2Triple Negative Breast Neoplasms
Phase 2Metastatic Gastric Cancer
Phase 2Advanced Breast Cancer
Phase 2Advanced Gastric Cancer
Phase 2Non-Small Cell Lung Cancer
Phase 3Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Phase 3Non-Small Cell Lung Cancer
Phase 3Multiple Myeloma
Phase 3Multiple Myeloma
Phase 3Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Phase 3Metastatic Castration-Sensitive Prostate Cancer
Phase 3Hormone-Sensitive Prostate Cancer
Phase 3Prostate Cancer
Phase 3Cancer of the Prostate
Phase 3Colorectal Neoplasms
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 2Uterine Neoplasms
Phase 2Uterine Cervical Neoplasms
Phase 2Biliary Tract Neoplasms
Phase 2Urologic Neoplasms
Phase 2HER2 Mutations Breast Neoplasms
Phase 3Breast Cancer
Phase 2Advanced or Metastatic Breast Cancer
Phase 2Head and Neck Cancer
Phase 2Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Phase 3Advanced Breast Cancer
Phase 2Non-Small Cell Lung Cancer
Phase 3Urothelial Carcinoma
Phase 3Healthy
Phase 3Healthy
Phase 2Ewing Sarcoma
Phase 2Solid Tumors
Phase 2Rhabdoid Tumor
Phase 2Rhabdomyosarcoma
Phase 2Neuroblastoma
Phase 2Medulloblastoma
Phase 2Diffuse Intrinsic Pontine Glioma
Phase 3Neoplasms
Phase 3Breast Cancer
Phase 2Head and Neck Cancer
Phase 2Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Phase 3Colorectal Neoplasms
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 3Neoplasms
Phase 3Hormone-Sensitive Prostate Cancer
Phase 3Prostate Cancer
Phase 3Cancer of the Prostate
Phase 3Colorectal Neoplasms
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Metastatic Castration-Sensitive Prostate Cancer
Phase 3Hormone-Sensitive Prostate Cancer
Phase 3Prostate Cancer
Phase 3Cancer of the Prostate
Phase 3Healthy
Phase 3COVID-19
Phase 3Colorectal Neoplasms
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 3Neoplasms
Phase 2Ewing Sarcoma
Phase 2Solid Tumors
Phase 2Rhabdoid Tumor
Phase 2Rhabdomyosarcoma
Phase 2Neuroblastoma
Phase 2Medulloblastoma
Phase 2Diffuse Intrinsic Pontine Glioma
Phase 3Breast Cancer
Phase 2Head and Neck Cancer
Phase 2Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Phase 3Healthy
Phase 3Advanced Non-Small Cell Lung Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Metastatic Non-small Cell Lung Cancer
Phase 3Lung Cancer
Phase 3Urothelial Carcinoma
Phase 3Melanoma
Phase 2Metastatic Colorectal Cancer
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 2Colorectal Neoplasms
Phase 2Exocrine Pancreatic Cancer
Phase 2Carcinoma, Squamous Cell of Head and Neck
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Breast Cancer
Phase 3Non-muscle-invasive Bladder Cancer
Phase 2Advanced Malignancies
Phase 2Non-Small Cell Lung Cancer
Phase 3Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Phase 3Metastatic Castration-resistant Prostate Cancer
Phase 3Myositis
Phase 3Hemophilia B
Phase 3Breast Cancer
Phase 2Liposarcoma
Phase 2Prostate Cancer
Phase 2Adenocarcinoma of Lung
Phase 2Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Phase 2Breast Cancer
Phase 3Advanced Non-Small Cell Lung Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Metastatic Non-small Cell Lung Cancer
Phase 3Lung Cancer
Phase 2Carcinoma, Renal Cell
Phase 2Advanced Renal Cell Carcinoma
Phase 2Renal Cancer
Phase 2Renal Neoplasm
Phase 2Clear Cell Renal Cell Carcinoma
Phase 2Metastatic Renal Cell Carcinoma
Phase 2Clear-cell Metastatic Renal Cell Carcinoma
Phase 2Advanced or Metastatic Renal Cell Carcinoma
Phase 2Metastatic/Advanced Renal Cell Carcinoma
Phase 2Urothelial Cancer
Phase 2Advanced/Metastatic Urothelial Cancer
Phase 2Urothelial Carcinoma
Phase 2Small Cell Lung Cancer
Phase 2Transformed Small Cell Lung Cancer
Phase 2Lung Neoplasms
Phase 2Carcinoma, Small Cell Lung
Phase 2Small Cell Cancer Of The Lung
Phase 3Intestinal Neoplasms
Phase 3Gastrointestinal Neoplasms
Phase 3Digestive System Neoplasms
Phase 3Neoplasms by Site
Phase 3Digestive System Diseases
Phase 3Gastrointestinal Diseases
Phase 3Colonic Diseases
Phase 3Intestinal Diseases
Phase 3Rectal Diseases
Phase 3Colorectal Neoplasms
Phase 2Carcinoma, Hepatocellular
Phase 2Hepatocellular Cancer
Phase 2Hepatocellular Carcinoma
Phase 2Unresectable Hepatocellular Carcinoma
Phase 2Liver Neoplasms
Phase 2Advanced Hepatocellular Carcinoma
Phase 2Metastatic Hepatocellular Carcinoma
Phase 2/3Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma
Phase 2/3Metastatic Gastric Cancer
Phase 2/3Gastroesophageal Junction Cancer
Phase 2/3Esophageal Adenocarcinoma
Phase 3Obesity
Phase 3Overweight and/or Obesity
Phase 3Diabetes, Type 2
Phase 3Type 2 Diabetes
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Multiple Myeloma
Phase 3Healthy
Phase 3Healthy
Phase 3COVID-19 Infection
Phase 3Breast Cancer
Phase 3Acute Treatment of Migraine
Phase 3Pediatric Migraine
Phase 2Hidradenitis Suppurativa
Phase 3Vitiligo
Phase 3Stable Nonsegmental Vitiligo
Phase 3Active Nonsegmental Vitiligo
Phase 3Severe Alopecia Areata
Phase 3Severe Alopecia Areata
Phase 3COVID-19
Phase 3Diffuse Large B-Cell Lymphoma
Phase 3Non-Small Cell Lung Cancer
Phase 2Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 3Menstrual Migraine
Phase 3Breast Cancer
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Non-Small Cell Lung Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Prostate Cancer
Phase 3Prostate Cancer
Phase 3Ulcerative Colitis
Phase 2Breast Cancer
Phase 2Uterine Neoplasms
Phase 2Uterine Cervical Neoplasms
Phase 2Biliary Tract Neoplasms
Phase 2Urologic Neoplasms
Phase 2HER2 Mutations Breast Neoplasms
Phase 3Breast Cancer
Phase 3Colorectal Neoplasms
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 2Non-Small Cell Lung Cancer
Phase 2Breast Cancer
Phase 2Uterine Neoplasms
Phase 2Uterine Cervical Neoplasms
Phase 2Biliary Tract Neoplasms
Phase 2Urologic Neoplasms
Phase 2HER2 Mutations Breast Neoplasms
Phase 2Non-Small Cell Lung Cancer
Phase 3Breast Cancer
Phase 3Colorectal Neoplasms
Phase 2Colorectal Carcinoma
Phase 2Gastric Adenocarcinoma
Phase 2GEJ Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Cholangiocarcinoma
Phase 2Gallbladder Carcinoma
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2HER2 Low Breast Neoplasms
Phase 2Stomach Neoplasms
Phase 2Triple Negative Breast Neoplasms
Phase 2Metastatic Gastric Cancer
Phase 2Advanced Breast Cancer
Phase 2Advanced Gastric Cancer
Phase 3Advanced Malignancies
Phase 3Ovarian Cancer
Phase 3Urothelial Cancer
Phase 3Solid Tumors
Phase 3Non-Small Cell Lung Cancer
Phase 3Breast Cancer
Phase 2/3Small Cell Lung Cancer (SCLC)
Phase 2/3Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma
Phase 2/3Metastatic Gastric Cancer
Phase 2/3Gastroesophageal Junction Cancer
Phase 2/3Esophageal Adenocarcinoma
Phase 2/3Sickle Cell Disease
Phase 2/3Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2/3Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2/3Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2Pneumococcal Disease
Phase 2Pneumococcal Disease
Phase 2Acute Lymphoblastic Leukemia
Phase 2Gram-negative Bacterial Infections
Phase 2Gram-negative Bacterial Infections
Phase 2Clostridoides Difficile Associated Disease
Phase 2Clostridoides Difficile Associated Disease
Phase 2Clostridoides Difficile Associated Disease
Phase 2Clostridoides Difficile Associated Disease
Phase 2Carcinoma, Renal Cell
Phase 2Advanced Renal Cell Carcinoma
Phase 2Renal Cancer
Phase 2Renal Neoplasm
Phase 2Clear Cell Renal Cell Carcinoma
Phase 2Metastatic Renal Cell Carcinoma
Phase 2Clear-cell Metastatic Renal Cell Carcinoma
Phase 2Advanced or Metastatic Renal Cell Carcinoma
Phase 2Metastatic/Advanced Renal Cell Carcinoma
Phase 2Carcinoma, Renal Cell
Phase 2Advanced Renal Cell Carcinoma
Phase 2Renal Cancer
Phase 2Renal Neoplasm
Phase 2Clear Cell Renal Cell Carcinoma
Phase 2Metastatic Renal Cell Carcinoma
Phase 2Clear-cell Metastatic Renal Cell Carcinoma
Phase 2Advanced or Metastatic Renal Cell Carcinoma
Phase 2Metastatic/Advanced Renal Cell Carcinoma
Phase 2Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 2Non-Small Cell Lung Cancer
Phase 2Ewing Sarcoma
Phase 2Solid Tumors
Phase 2Rhabdoid Tumor
Phase 2Rhabdomyosarcoma
Phase 2Neuroblastoma
Phase 2Medulloblastoma
Phase 2Diffuse Intrinsic Pontine Glioma
Phase 2Multiple Myeloma
Phase 2Urothelial Cancer
Phase 2Advanced/Metastatic Urothelial Cancer
Phase 2Urothelial Carcinoma
Phase 2Ulcerative Colitis
Phase 2Diffuse Large B-Cell Lymphoma
Phase 2Heart Failure
Phase 2Acute Lymphoblastic Leukemia
Phase 2Carcinoma, Hepatocellular
Phase 2Hepatocellular Cancer
Phase 2Hepatocellular Carcinoma
Phase 2Unresectable Hepatocellular Carcinoma
Phase 2Liver Neoplasms
Phase 2Advanced Hepatocellular Carcinoma
Phase 2Metastatic Hepatocellular Carcinoma
Phase 2Pneumococcal Disease
Phase 2Heart Failure
Phase 2Diffuse Large B-Cell Lymphoma
Phase 2Heart Failure
Phase 2Obesity and Obesity-related Medical Conditions
Phase 2Pneumococcal Disease
Phase 2Diffuse Large B-Cell Lymphoma
Phase 2Gram-negative Bacterial Infection
Phase 2Gram-negative Bacterial Infection
Phase 2Immune Thrombocytopenia
Phase 2Hemophilia B
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Small Cell Lung Cancer
Phase 2Ovarian Cancer
Phase 2Breast Cancer
Phase 2Advanced or Metastatic Breast Cancer
Phase 2Atopic Dermatitis
Phase 2Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Phase 2Pneumococcal Disease
Phase 2Breast Cancer
Phase 2Ewing Sarcoma
Phase 2Solid Tumors
Phase 2Rhabdoid Tumor
Phase 2Rhabdomyosarcoma
Phase 2Neuroblastoma
Phase 2Medulloblastoma
Phase 2Diffuse Intrinsic Pontine Glioma
Phase 2Colorectal Neoplasms
Phase 2Exocrine Pancreatic Cancer
Phase 2Carcinoma, Squamous Cell of Head and Neck
Phase 2Non-Small Cell Lung Cancer
Phase 2Healthy Adults
Phase 2Ewing Sarcoma
Phase 2Solid Tumors
Phase 2Rhabdoid Tumor
Phase 2Rhabdomyosarcoma
Phase 2Neuroblastoma
Phase 2Medulloblastoma
Phase 2Diffuse Intrinsic Pontine Glioma
Phase 2Healthy Adults
Phase 2Healthy Adults
Phase 2Healthy Adults
Phase 2Healthy Adults
Phase 2Healthy Adults
Phase 2Healthy Adults
Phase 2Breast Cancer
Catalyst Calendar
No catalyst events on record for yet. Check back after the next daily ingest.